Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By boosting these receptors, Retatrutide suppresses appetite, {promotesglucose regulation, and ultimately leads to significant weight loss. While research is